Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

AmericaBy CountryBy RegionFor organizationsGrantOpportunities

Grant Decoding Neurodegeneration

Investigating Distinct and Overlapping Mechanisms in TDP-43 Proteinopathies

Summary:
This R01 research grant, funded by the National Institutes of Health (NIH), seeks to investigate the underlying mechanisms behind various neurodegenerative diseases associated with the abnormal accumulation of the protein TDP-43. These diseases, collectively known as TDP-43 proteinopathies, include:

  • Limbic-predominant age-related TDP-43 encephalopathy (LATE)
  • Frontotemporal dementia (FTD)
  • Amyotrophic lateral sclerosis (ALS)
  • Other atypical dementia and related disorders (ADRDs)

The project aims to identify both distinct and overlapping mechanisms contributing to the development and progression of these diverse pathologies. By understanding these mechanisms, researchers hope to develop more targeted therapies and interventions for these currently incurable diseases.

Sponsor:

National Institutes of Health (NIH)

Eligibility:

The grant is open to researchers affiliated with U.S. institutions, including:

  • Universities and colleges
  • Medical schools and research institutions
  • Non-profit organizations

Benefits:

  • Funding to support research costs for a period of up to 5 years
  • Opportunity to contribute to groundbreaking research on TDP-43 proteinopathies
  • Collaboration with leading experts in the field
  • Potential for significant advancements in the understanding and treatment of these diseases

Deadline:

Oct 04, 2024.

Apply Now

Related Articles

Back to top button
What do you like about this page?

0 / 400